Genetic characterization of amyotrophic lateral sclerosis in the clinic


  • An amyotrophic lateral sclerosis (ALS) Genetic Access Program (GAP) provided a genetic diagnosis to approximately a third of patients, and may be useful as a model for genetic testing in other clinics.

Why this matters

  • The ALS GAP has been designed as a pilot testing and counseling program, with the aim to increase access to these services for people with ALS.

  • Results from the ALS GAP could provide more data on the incidence of genetic forms of ALS and identify candidates for clinical trials.